JP2002531495A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002531495A5 JP2002531495A5 JP2000586320A JP2000586320A JP2002531495A5 JP 2002531495 A5 JP2002531495 A5 JP 2002531495A5 JP 2000586320 A JP2000586320 A JP 2000586320A JP 2000586320 A JP2000586320 A JP 2000586320A JP 2002531495 A5 JP2002531495 A5 JP 2002531495A5
- Authority
- JP
- Japan
- Prior art keywords
- herpes simplex
- simplex virus
- virus
- effective amount
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 11
- 241000700588 Human alphaherpesvirus 1 Species 0.000 claims 6
- 241001529453 unidentified herpesvirus Species 0.000 claims 6
- 241000700584 Simplexvirus Species 0.000 claims 5
- 208000036142 Viral infection Diseases 0.000 claims 5
- 230000009385 viral infection Effects 0.000 claims 5
- 208000004898 Herpes Labialis Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 241000701022 Cytomegalovirus Species 0.000 claims 2
- 241000701074 Human alphaherpesvirus 2 Species 0.000 claims 2
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 claims 2
- 241001502974 Human gammaherpesvirus 8 Species 0.000 claims 2
- 241000701027 Human herpesvirus 6 Species 0.000 claims 2
- 206010067152 Oral herpes Diseases 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 239000003443 antiviral agent Substances 0.000 claims 2
- SNPPWIUOZRMYNY-UHFFFAOYSA-N bupropion Chemical compound CC(C)(C)NC(C)C(=O)C1=CC=CC(Cl)=C1 SNPPWIUOZRMYNY-UHFFFAOYSA-N 0.000 claims 2
- 229960001058 bupropion Drugs 0.000 claims 2
- 239000006186 oral dosage form Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 208000007514 Herpes zoster Diseases 0.000 claims 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical group N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims 1
- 229960004150 aciclovir Drugs 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13549498P | 1998-12-08 | 1998-12-08 | |
| US60/135,494 | 1998-12-08 | ||
| PCT/AU1999/001089 WO2000033827A1 (en) | 1998-12-08 | 1999-12-07 | Bupropion to treat viral diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002531495A JP2002531495A (ja) | 2002-09-24 |
| JP2002531495A5 true JP2002531495A5 (https=) | 2005-05-19 |
| JP4166955B2 JP4166955B2 (ja) | 2008-10-15 |
Family
ID=22468359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000586320A Expired - Fee Related JP4166955B2 (ja) | 1998-12-08 | 1999-12-07 | ウイルス疾患を処置するためのビュープロピオン |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6512011B1 (https=) |
| EP (1) | EP1156791B1 (https=) |
| JP (1) | JP4166955B2 (https=) |
| AT (1) | ATE295159T1 (https=) |
| AU (1) | AU762624B2 (https=) |
| BR (1) | BR9916963A (https=) |
| CA (1) | CA2349487C (https=) |
| DE (1) | DE69925312T2 (https=) |
| ES (1) | ES2242438T3 (https=) |
| HK (1) | HK1042239B (https=) |
| MX (1) | MXPA01005725A (https=) |
| NZ (1) | NZ512716A (https=) |
| PT (1) | PT1156791E (https=) |
| WO (1) | WO2000033827A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030134905A1 (en) * | 2002-01-11 | 2003-07-17 | Reindler Christopher William | Bupropion to treat viral diseases |
| DE102004063132A1 (de) * | 2004-12-22 | 2006-07-06 | Schmiegel, Wolff, Prof. Dr. | Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C |
| ZA200711123B (en) | 2005-06-27 | 2009-08-26 | Biovail Lab Int Srl | Modified-release formulations of a bupropion salt |
| RU2012108048A (ru) * | 2009-08-10 | 2013-09-20 | Биокопи Лимитед | Лечение вирусных инфекций |
| GB2477584A (en) * | 2010-02-04 | 2011-08-10 | Biocopea Ltd | A compound for use in treating an acute viral infection |
| CN108721262A (zh) * | 2017-04-13 | 2018-11-02 | 中国科学院武汉病毒研究所 | 安非他酮在制备治疗或预防流感病毒感染的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4438138A (en) * | 1982-12-06 | 1984-03-20 | Burroughs Wellcome Co. | Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone |
| US4507323A (en) * | 1984-07-25 | 1985-03-26 | Burroughs Wellcome Co. | Treatment of psychosexual dysfunctions |
| US5753712A (en) * | 1994-02-18 | 1998-05-19 | Pinsker; Walter | Treatment of migraine headaches and formulations |
| AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
-
1999
- 1999-12-07 WO PCT/AU1999/001089 patent/WO2000033827A1/en not_active Ceased
- 1999-12-07 PT PT99960723T patent/PT1156791E/pt unknown
- 1999-12-07 DE DE69925312T patent/DE69925312T2/de not_active Expired - Fee Related
- 1999-12-07 BR BR9916963-0A patent/BR9916963A/pt not_active IP Right Cessation
- 1999-12-07 AU AU17629/00A patent/AU762624B2/en not_active Ceased
- 1999-12-07 HK HK02103897.6A patent/HK1042239B/en not_active IP Right Cessation
- 1999-12-07 CA CA002349487A patent/CA2349487C/en not_active Expired - Fee Related
- 1999-12-07 ES ES99960723T patent/ES2242438T3/es not_active Expired - Lifetime
- 1999-12-07 JP JP2000586320A patent/JP4166955B2/ja not_active Expired - Fee Related
- 1999-12-07 AT AT99960723T patent/ATE295159T1/de not_active IP Right Cessation
- 1999-12-07 NZ NZ512716A patent/NZ512716A/en unknown
- 1999-12-07 EP EP99960723A patent/EP1156791B1/en not_active Expired - Lifetime
- 1999-12-07 US US09/787,024 patent/US6512011B1/en not_active Expired - Fee Related
- 1999-12-07 MX MXPA01005725A patent/MXPA01005725A/es not_active IP Right Cessation
-
2002
- 2002-06-25 US US10/178,498 patent/US20020173551A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| O’Brien et al. | Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy | |
| JP3350055B2 (ja) | コロイド状二酸化ケイ素を含むバラシクロビール錠剤 | |
| MY117892A (en) | Therapeutic compounds | |
| AU644095B2 (en) | Antiviral compounds | |
| SK3072003A3 (en) | Methods for delaying recurrence of herpes virus symptoms | |
| EP0270317A3 (en) | Pharmaceutical compositions for the treatment of diseases caused by viruses | |
| SG67344A1 (en) | Methods for treating viral infections | |
| JP2005508955A5 (https=) | ||
| JP2002528502A5 (https=) | ||
| CA2373833A1 (en) | Medicinal compositions for preventing or treating viral myocarditis | |
| JP2002531495A5 (https=) | ||
| Abdel-Haq et al. | New antiviral agents | |
| US8450330B2 (en) | Pharmaceutical acceptable composition containing non-steroidal anti-inflammatory drug and local anesthetics | |
| KR101951010B1 (ko) | 대청엽 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물 | |
| ES2105923A1 (es) | Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv). | |
| JPH0347251B2 (https=) | ||
| US4828830A (en) | Method and composition for prophylaxis and treatment of viral infections | |
| WO2001022950A3 (en) | Diosolane nucleoside analogs for the treatment or prevention of viral infection | |
| CA2349487A1 (en) | Bupropion to treat viral diseases | |
| Colgan et al. | Antiviral drugs in the immunocompetent host: part I. Treatment of hepatitis, cytomegalovirus, and herpes infections | |
| CN1084622C (zh) | 药物 | |
| JP2007516296A5 (https=) | ||
| JP2005154283A5 (https=) | ||
| RU2190402C1 (ru) | Противовирусное средство | |
| Nicholson | Antiviral Therapy: Respiratory Infections, Genital Herpes, and Herpetic Keratitis |